Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-24-001219
Filing Date
2024-02-13
Accepted
2024-02-13 21:00:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 d10965250_13g-a.htm SC 13G/A 124305
  Complete submission text file 0000919574-24-001219.txt   126230
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Subject) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-78541 | Film No.: 24631523
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 731 ALEXANDER ROAD BUILDING 2, SUITE 500 PRINCETON NJ 08540
Business Address 731 ALEXANDER ROAD BUILDING 2, SUITE 500 PRINCETON NJ 08540 609-419-1800
CAXTON CORP (Filed by) CIK: 0001388551 (see all company filings)

EIN.: 222437619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A